Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have completed a course of chemotherapy using one or more of the following drugs: paclitaxel, docetaxel, oxaliplatin, cisplatin, vincristine, thalidomide, and/or bortezomib
- People who have been diagnosed with chemotherapy-induced peripheral neuropathy (CIPN) — a type of nerve damage caused by chemotherapy
- People aged 18 years or older
- People who do not have a diagnosed or noticeable psychiatric or neurological condition (such as dementia or psychosis) that could interfere with taking part in the study
- People who speak Dutch
- People who have signed a form giving their informed consent to participate
Who may not be able to join:
- People who are currently taking prescription medication at a stable dose specifically for peripheral neuropathy — including gabapentin, pregabalin (Lyrica), nortriptyline, amitriptyline, duloxetine (Cymbalta), or venlafaxine
- People who have a severe or unstable heart, breathing, or musculoskeletal (bones, muscles, or joints) condition
- People who miss more than two laser treatment sessions in a row during the trial
- People with very dark skin tone, classified as skin type VI on the Fitzpatrick scale (confirm with trial site regarding how this is assessed)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jeroen mebis, Prof. Dr., Jessa Hospital
Phone: 011 33 72 21
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Modified total neuropathy score (mTNS); Modified total neuropathy score (mTNS); Modified total neuropathy score (mTNS); Pain score; Pain score; Pain score; Mobility score; Mobility score; Mobility score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.